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The search for anorallyadministered and stable penicillin prepa-
ration with high therapeutic efficacy led to the recent discovery that
the benzyl ester of penicillin, given orally, was at least equal in pro-
tective effect to the equivalent weight of sodium penicillin adminis-
tered parenterally to mice that had received lethal doses of pneumo-
cocci and hemolytic streptococci by intraperitoneal injection.' Fol-
lowing the demonstration that benzyl penicillin was non-toxic to
experimental animals and human volunteers, preliminary therapeu-
tic tests had been carried out on a group of infants with impetigo,2
and the rapidity with which the lesions cleared suggested a definite
curative effect.
Recently, a patient with chronic bacteremia due to an organism
inhibitable by penicillin both in vitro and in vivo, yet refractory to
cureby the drug, offered himself as a testsubject forbenzylpenicillin.
Should the drug have proved as effective in maintaining sterility
of the blood as did sodium and calcium penicillin glven parenterally,
thepatient could conceivably have been kept indefinitely in a state of
therapeutic remission even though not cured of his infection.
Experimental
The test subject was a 44-year-old man with rheumatic mitral
and aortic valvular lesions, in whom the syndrome of subacute bac-
terial endocarditis developed in June, 1944. The infecting organ-
ism, Streptococcuws viridans, provedinhi-bitablebypenicillinconcentra-
tions of 0.03 to 0.04 units per cc. of culture. Treatment for about 10
months with water-soluble penicillin in daily parenteral doses rang-
ing from 250,000 to 600,000 units administered either in fraction-
ated intramuscular injections at two-hour intervals or by continuous
intravenous drip was regularly attended by dinical remission and
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sterilization of the blood. However, whenever treatment was inter-
rupted, in the belief that cure had been effected, Streptococcus W'in-
dans always promptly reappeared in the blood. The extraction of
an infected tooth and removal of the spleen, which were suspected
as foci of reinfection, did not alter the course of events. The infect-
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July 19 to December 14: Penicillin, 300,000 to 600,000 units in peanut oil and
beeswax daily, again brought about and maintained sterility of the blood.
* Culture positive; colonies not counted.
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ing organism did not change its resistance in vitro to penicillin dur-
ing this long period.
The uniformity ofthe clinical response undertherapy,theprompt
and consistent eradication of bacteremia with repeated cycles of par-
enteral penicillin in daily doses of 250,000 or more units, the failure
of the infecting organism to alter its sensitivity to penicillin, and the
regular, early recurrence of bacteremia with interruption of the
penicillin were circumstances which made this patient a unique test-
subject for comparing orally administered benzyl penicillin* with
parenterally administered sodium penicillin. The results of such a
trial through a 25-day period are summarized in the table.
The 94.9 grams of benzyl penicillin ingested in the course of
this experiment represented 158,000,000 units of sodium penicillin,
and the 14-gram doses of the two concluding days represented doses
of 19,500,000 units of sodium penicillin daily. As far as we are
aware, this is a far greater dosage of penicillin molecules than has
ever been administered to man. No untoward effects were observed
from the lbenzyl penicillin on the blood count, urine, or tempera-
ture. During the last 10 days of treatment the bowel movements
were sometimes two or three per day instead of the usual one, and
the consistency of the stools seemed softer than usual but they were
not diarrheal. The patient also noted some belching and minimal
uneasiness in the epigastrium, without nausea, distress, or pain. An
eruption did not appear.
From the observation that bacteremia was present consistently
throughout the period of administration of benzyl penicillin, regard-
less of dose, it is apparent that the compound was ineffective in vivo.
Benzyl penicillin was also tested in vitro by inoculating solutions
of the drug with the streptococcus recovered previously from the
patient's blood; growth was not prevented.
Comment
Because benzyl penicillin in massive doses failed to abolish bac-
teremia in a patient whose blood could regularly be sterilized with
parenterally administered sodium or calcium penicillin, the evidence
is that the benzyl penicillin exerted less, if any, antibacterial effect
than did 250,000 units daily of a water-soluble salt of penicillin
given parenterally.
* The benzyl penicillin was furnished in solution in polyethylene glycol No. 400.380 YALE JOURNAL OF BIOLOGY AND MEDICINE
The failure of solutions of benzyl penicillin to inhibit growth of
the infecting bacterium in vitro was already known from previous
observations,l which indicated that an enzyme, present in the serum
and kidney extract of rodents, was essential for releasing the peni-
cillin from the benzyl ester compound. Our observations suggest
several explanations for our failure to demonstrate antibacterial
effects in vivo: (1) that the benzyl penicillin was either not absorbed
or inadequately absorbed; (2) that the blood of man lacks the hypo-
thetical enzyme, seemingly present in rodents, necessary for li'ber-
ating active penicillin from the ester.
Summary
Benzyl penicillin in massive oral doses failed to sterilize the
blood in a patient with chronic bacteremia whose blood could be
regularly cleared of the infecting organism (Streptococcus viridans)
by parenterally administered penicillin in daily doses oif 250,000
units. No significant toxic effects were noted from the large quanti-
ties ofbenzyl penicillin ingested.
The observations indicate that orally administered benzyl peni-
cillin does not produce an effective concentration of penicillin in the
blood in man, and in this respect a species difference from rodents
is implied.
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